BioAtla, Inc. (BCAB) income statement
BCABOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.31−0.05 (-3.68%)
Close on Oct 19, 2026Market cap $2.18MP/E –Yield –
BioAtla, Inc. financial ratios
See a number that looks wrong?